journal article·2009-03

Biofilm inhibitory coatings formulated from glass polyalkenoate cement chemistry: an evaluation of their adhesive nature

A. Coughlan, D. Boyd, M. R. Towler

Journal of Materials Science· Volume 44· Issue 6
Publisher page

Abstract

Glass polyalkenoate cements (GPCs), are formed by the reaction between an ion-leachable glass and an aqueous solution of polyacrylic acid (PAA) [1]. GPCs may also be formed from a combination of polyalkenoaic acids and various fillers such as those based on the use of additional fillers like N,N0-methylenebisacrylamide to increase their strength and toughness [2]. These materials can be formulated to be anticariostatic [3] by the inclusion of fluoride in the glass phase of GPCs which subsequently releases beneficial amounts of the F ion into the oral environment [4, 5]. Commercially available GPCs are all based on calcium alumino silicate glass chemistry [6]. Aluminium is present in the glass because it can isomorphically replace the SiO4 tetrahedra within the glass structure. This causes a local charge imbalance within the structure, resulting in the acid degradability of the glass [7]. More importantly, aluminium is essential for the mechanical integrity of the cement as the ions undergo cement forming [8]. However, the presence of aluminium retards the medical and surgical applications of such cements as aluminium ions (Al) released in vivo can cause demineralisation of the bone [9] and has been implicated in the pathogenesis of degenerative brain diseases including Parkinson’s and Alzheimer’s disease [10, 11]. The authors have developed GPCs based on calcium zinc silicate, rather than calcium alumino silicate glasses [3, 12–14], where the zinc ion (Zn) replaces Al, as it can act as a network modifying oxide in the glass phase [9, 15]. A serendipitous effect of developing zinc-based GPCs was that these cements have antimicrobial ability [3] as the release of zinc ions inhibits bacterial growth. The silver ion (Ag) also has an acknowledged antibacterial effect [16, 17] and the authors have recently developed coatings based on silver/zinc-based GPCs which have proven bactericidal efficacy against S. aureus and P. aeruginosa, common aetiological agents of hospital-acquired infections [18]. In that study, the authors also reported that these GPC coatings adhere to Ti6Al4V titanium alloy. Conventional GPCs are inherently capable of chemically bonding to metal substrates [19] with the assistance of the oxide layer which forms on the alloy surface [20]. However, the authors have not yet reported on the extent of this bonding between these silver/zinc-based GPC coatings and metal. There have been previous studies to create novel testing modalities to evaluate the bond strength of luting cements some of which have been previously reported by the authors [21]. One in-house study involved sandwiching the GPC between hydroxyapatite (HA, a material comparable to the mineral phase of bone) and hardened steel discs [21]. However, the possible applications of these silver/zinc-based GPC coatings include a range of clinical applications where biofilms can proliferate, such as on hard surfaces (surgical stainless steel) [22] and flexible surfaces (tubing for catheters and aspirators) [23], and so the objective of this study is to modify the conventional T-peel test [24], historically employed to determine resistance of a bonded assembly of two adherents when at least one adherent is flexible [24], to quantify the bond between tape and a surgical metal substrate bonded by a luting GPC. There are two types of peel A. Coughlan M. R. Towler (&) Clinical Materials Unit, Materials and Surface Science Institute, University of Limerick, National Technological Park, Limerick, Ireland e-mail: Mark.Towler@ul.ie
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Dental materials and restorations · Endodontics and Root Canal Treatments · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Crisp S, Wilson AD (1974) J Dent Res 53:142010.1177/00220345740530062101 ↗
2. Acosta DA, Funkhouser GP, Grady BP (2007) J Mater Sci 42:3632. doi: https://doi.org/10.1007/s10853-006-0357-410.1007/s10853-006-0357-4 ↗
3. Boyd D, Li H, Tanner DA, Towler MR, Wall JG (2006) J Mater Sci Mater Med 17:48910.1007/s10856-006-8930-6 ↗
4. Forss H (1993) J Dent Res 72:125710.1177/00220345930720081601 ↗
5. Mitra SB (1991) Abstr Pap Am Chem Soc 202:262
6. Nicholson JW (1998) Biomaterials 19:48510.1016/S0142-9612(97)00128-2 ↗
7. Griffin SG, Hill RG (1999) Biomaterials 20:157910.1016/S0142-9612(99)00058-7 ↗
8. Wilson AD, Nicholson JW (1993) Acid-base cements. Their biomedical and industrial applications. Cambridge University Press, Cambridge10.1017/CBO9780511524813 ↗
9. Blades MC, Moore DP, Revell PA, Hill R (1998) J Mater Sci Mater Med 9:70110.1023/A:1008990516159 ↗
10. Exley C (1999) J Inorg Biochem 76:13310.1016/S0162-0134(99)00125-7 ↗
11. Zatta P, Kiss T, Suwalsky M, Berthon G (2002) Coord Chem Rev 228:27110.1016/S0010-8545(02)00074-7 ↗
12. Boyd D, Towler MR (2005) J Mater Sci Mater Med 16:84310.1007/s10856-005-3578-1 ↗
13. Boyd D, Towler MR, Law RV, Hill RG (2006) J Mater Sci Mater Med 17:39710.1007/s10856-006-8465-x ↗
14. Boyd D, Towler MR, Wren AW, Clarkin OM, Tanner DA (2008) J Mater Sci 43:1170. doi: https://doi.org/10.1007/s10853-007-2362-710.1007/s10853-007-2362-7 ↗
15. Quarles LD, Murphy G, Vogler JB, Drezner MK (1990) J Bone Miner Res 5:62510.1002/jbmr.5650050612 ↗
16. Sampath LA, Chowdhury N, Caraos L, Modak SM (1995) J Hosp Infect 30:20110.1016/S0195-6701(95)90315-1 ↗
17. Cook G, Costerton JW, Darouiche RO (2000) Int J Antimicrob Agents 13:16910.1016/S0924-8579(99)00120-X ↗
18. Coughlan A, Boyd D, Douglas CWI, Towler MR (2008) J Mater Sci Mater Med 19(12):3555–356010.1007/s10856-008-3519-x ↗
19. White LW (1986) J Clin Orthod 20:387
20. Hibino Y, Kuramochi K-I, Hoshino T, Moriyama A, Watanabe Y, Nakajima H (2002) Dent Mater 18:55210.1016/S0109-5641(01)00086-0 ↗
21. Rushe N, Towler MR (2006) J Mater Sci 41:1251. doi: https://doi.org/10.1007/s10853-005-2144-z10.1007/s10853-005-2144-z ↗
22. Borden AJVD, Werf HVD, Mei HCVD, Busscher HJ (2004) Appl Environ Microbiol 70:687110.1128/AEM.70.11.6871-6874.2004 ↗
23. Falkinham JO (2007) J Med Microbiol 56:25010.1099/jmm.0.46935-0 ↗
24. ISO:8510-1:1990 (1990) Adhesives-peel test for a flexible-bonded-to-rigid test specimen assembly. Part 1: 90° peel
25. ISO:8510-2:1990 (1990) Adhesives-peel test for a flexible-bonded-to-rigid test specimen assembly. Part 2: 180° peel
26. Dahlquist CA (1969) Treatise on adhesion and adhesives. Marcel Dekker, New York
27. Williams JA, Kauzlarich JJ (2006) Tribol Int 38:95110.1016/j.triboint.2005.07.024 ↗
28. ISO:11405 (1994) Case postal 56. International Standards Organisation, Switzerland
29. Farah CS, Orton VG, Collard SM (1998) Aust Dent J 43:8110.1111/j.1834-7819.1998.tb06095.x ↗
30. Setien VJ, Armstrong SR, Wefel JS (2005) Dent Mater 21:49810.1016/j.dental.2004.07.015 ↗
31. Burrow MF, Nopnakeepong U, Phrukkanon S (2002) Dent Mater 18:23910.1016/S0109-5641(01)00041-0 ↗
32. Gibba AJ, Katonab TR (2006) Am J Orthod Dentofacial Orthop 130:699e.1
33. Summers A, Kao E, Gilmore J, Gunel E, Ngan P (2004) Am J Orthod Dentofacial Orthop 126:20010.1016/j.ajodo.2003.06.013 ↗
34. Rix D, Foley TF, Mamandras A (2000) Am J Orthod Dentofacial Orthop 119:3610.1067/mod.2001.110519 ↗
35. Kula KS, Nash TD, Purk JH (2003) Orthod Craniofac Res 6:9610.1034/j.1600-0854.2003. c242.x ↗
36. Paschos E, Okuka S, Ilie N, Huth KC, Hickel R, Rudzki-Janson I (2006) J Orofac Orthop 67:19610.1007/s00056-006-0541-9 ↗
37. Al-Jazairya YH (2001) J Prosthet Dent 85:39610.1067/mpr.2001.114824 ↗
38. Hotz P, Mclean JW, Sced I, Wilson AD (1977) Br Dent J 142:4110.1038/sj.bdj.4803864 ↗
39. Powis DR, Folleras T, Merson SA, Wilson AD (1982) J Dent Res 61:141610.1177/00220345820610120801 ↗